Central sensitization: Implications for the diagnosis and treatment of pain
Pain · 2010 · 5,114 citationsOpen access
No retraction on record in OpenAlex.Check Crossref now
Cite this paper
Woolf, C. J. (2010). Central sensitization: Implications for the diagnosis and treatment of pain. Pain, 152(3), S2-S15. https://doi.org/10.1016/j.pain.2010.09.030
In text: (Woolf, 2010)
Ask a question about this research
One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.
Abstract
Nociceptor inputs can trigger a prolonged but reversible increase in the excitability and synaptic efficacy of neurons in central nociceptive pathways, the phenomenon of central sensitization. Central sensitization manifests as pain hypersensitivity, particularly dynamic tactile allodynia, secondary punctate or pressure hyperalgesia, aftersensations, and enhanced temporal summation. It can be readily and rapidly elicited in human volunteers by diverse experimental noxious conditioning stimuli to skin, muscles or viscera, and in addition to producing pain hypersensitivity, results in secondary changes in brain activity that can be detected by electrophysiological or imaging techniques. Studies in clinical cohorts reveal changes in pain sensitivity that have been interpreted as revealing an important contribution of central sensitization to the pain phenotype in patients with fibromyalgia, osteoarthritis, musculoskeletal disorders with generalized pain hypersensitivity, headache, temporomandibular joint disorders, dental pain, neuropathic pain, visceral pain hypersensitivity disorders and post-surgical pain. The comorbidity of those pain hypersensitivity syndromes that present in the absence of inflammation or a neural lesion, their similar pattern of clinical presentation and response to centrally acting analgesics, may reflect a commonality of central sensitization to their pathophysiology. An important question that still needs to be determined is whether there are individuals with a higher inherited propensity for developing central sensitization than others, and if so, whether this conveys an increased risk in both developing conditions with pain hypersensitivity, and their chronification. Diagnostic criteria to establish the presence of central sensitization in patients will greatly assist the phenotyping of patients for choosing treatments that produce analgesia by normalizing hyperexcitable central neural activity. We have certainly come a long way since the first discovery of activity-dependent synaptic plasticity in the spinal cord and the revelation that it occurs and produces pain hypersensitivity in patients. Nevertheless, discovering the genetic and environmental contributors to and objective biomarkers of central sensitization will be highly beneficial, as will additional treatment options to prevent or reduce this prevalent and promiscuous form of pain plasticity.
Related papers
- The McGill Pain Questionnaire: Major properties and scoring methods1975
- The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises2020
- Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale2001
- Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment2005
- Carrageenin-Induced Edema in Hind Paw of the Rat as an Assay for Antiinflammatory Drugs1962
Metadata from OpenAlex (CC0). Citations are generated from the published record.